These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. A cross-sectional study of hydroxychloroquine concentrations and effects in people with systemic lupus erythematosus. Carmichael SJ; Day RO; Tett SE Intern Med J; 2013 May; 43(5):547-53. PubMed ID: 23425382 [TBL] [Abstract][Full Text] [Related]
6. Hydroxychloroquine Serum Concentrations and Flares of Systemic Lupus Erythematosus: A Longitudinal Cohort Analysis. Mok CC; Penn HJ; Chan KL; Tse SM; Langman LJ; Jannetto PJ Arthritis Care Res (Hoboken); 2016 Sep; 68(9):1295-302. PubMed ID: 26749299 [TBL] [Abstract][Full Text] [Related]
7. Very low blood hydroxychloroquine concentration as an objective marker of poor adherence to treatment of systemic lupus erythematosus. Costedoat-Chalumeau N; Amoura Z; Hulot JS; Aymard G; Leroux G; Marra D; Lechat P; Piette JC Ann Rheum Dis; 2007 Jun; 66(6):821-4. PubMed ID: 17324970 [TBL] [Abstract][Full Text] [Related]
8. Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus. Costedoat-Chalumeau N; Amoura Z; Hulot JS; Hammoud HA; Aymard G; Cacoub P; Francès C; Wechsler B; Huong du LT; Ghillani P; Musset L; Lechat P; Piette JC Arthritis Rheum; 2006 Oct; 54(10):3284-90. PubMed ID: 17009263 [TBL] [Abstract][Full Text] [Related]
9. Hydroxychloroquine Levels throughout Pregnancies Complicated by Rheumatic Disease: Implications for Maternal and Neonatal Outcomes. Balevic SJ; Cohen-Wolkowiez M; Eudy AM; Green TP; Schanberg LE; Clowse MEB J Rheumatol; 2019 Jan; 46(1):57-63. PubMed ID: 30275257 [TBL] [Abstract][Full Text] [Related]
10. Factors Related to Blood Hydroxychloroquine Concentration in Patients With Systemic Lupus Erythematosus. Yeon Lee J; Lee J; Ki Kwok S; Hyeon Ju J; Su Park K; Park SH Arthritis Care Res (Hoboken); 2017 Apr; 69(4):536-542. PubMed ID: 27390146 [TBL] [Abstract][Full Text] [Related]
11. Association of Higher Hydroxychloroquine Blood Levels With Reduced Thrombosis Risk in Systemic Lupus Erythematosus. Petri M; Konig MF; Li J; Goldman DW Arthritis Rheumatol; 2021 Jun; 73(6):997-1004. PubMed ID: 33403833 [TBL] [Abstract][Full Text] [Related]
12. Population Pharmacokinetics of Hydroxychloroquine in Japanese Patients With Cutaneous or Systemic Lupus Erythematosus. Morita S; Takahashi T; Yoshida Y; Yokota N Ther Drug Monit; 2016 Apr; 38(2):259-67. PubMed ID: 26587870 [TBL] [Abstract][Full Text] [Related]
13. Clinical Significance of Monitoring Hydroxychloroquine Levels in Patients With Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis. Garg S; Unnithan R; Hansen KE; Costedoat-Chalumeau N; Bartels CM Arthritis Care Res (Hoboken); 2021 May; 73(5):707-716. PubMed ID: 32004406 [TBL] [Abstract][Full Text] [Related]
14. Health status and concomitant prescription of immunosuppressants are risk factors for hydroxychloroquine non-adherence in systemic lupus patients with prolonged inactive disease. Iudici M; Pantano I; Fasano S; Pierro L; Charlier B; Pingeon M; Dal Piaz F; Filippelli A; Izzo V Lupus; 2018 Feb; 27(2):265-272. PubMed ID: 28659047 [TBL] [Abstract][Full Text] [Related]
15. Steady-state pharmacokinetics of hydroxychloroquine in patients with cutaneous lupus erythematosus. Al-Rawi H; Meggitt SJ; Williams FM; Wahie S Lupus; 2018 Apr; 27(5):847-852. PubMed ID: 28862574 [TBL] [Abstract][Full Text] [Related]
16. Blood concentrations of hydroxychloroquine and its desethyl derivative correlate negatively with the percentage of CD45RO+ cells among CD4+ lymphocytes in hydroxychloroquine-treated lupus patients. Sailler L; Puissant B; Méliani P; Castex JO; Saivin S; Adoue D; Fournie B; Arlet P; Montastruc JL; Lapeyre-Mestre M; Pourrat J; Blancher A Ann N Y Acad Sci; 2007 Jun; 1108():41-50. PubMed ID: 17893969 [TBL] [Abstract][Full Text] [Related]
17. Hydroxychloroquine-induced pigmentation in patients with systemic lupus erythematosus: a case-control study. Jallouli M; Francès C; Piette JC; Huong du LT; Moguelet P; Factor C; Zahr N; Miyara M; Saadoun D; Mathian A; Haroche J; De Gennes C; Leroux G; Chapelon C; Wechsler B; Cacoub P; Amoura Z; Costedoat-Chalumeau N; JAMA Dermatol; 2013 Aug; 149(8):935-40. PubMed ID: 23824340 [TBL] [Abstract][Full Text] [Related]
18. Hydroxychloroquine Blood Levels Predict Hydroxychloroquine Retinopathy. Petri M; Elkhalifa M; Li J; Magder LS; Goldman DW Arthritis Rheumatol; 2020 Mar; 72(3):448-453. PubMed ID: 31532077 [TBL] [Abstract][Full Text] [Related]
19. Cumulative dose of hydroxychloroquine is associated with a decrease of resting heart rate in patients with systemic lupus erythematosus: a pilot study. Cairoli E; Danese N; Teliz M; Bruzzone MJ; Ferreira J; Rebella M; Cayota A Lupus; 2015 Oct; 24(11):1204-9. PubMed ID: 25852050 [TBL] [Abstract][Full Text] [Related]
20. Hydroxychloroquine: a multifaceted treatment in lupus. Costedoat-Chalumeau N; Dunogué B; Morel N; Le Guern V; Guettrot-Imbert G Presse Med; 2014 Jun; 43(6 Pt 2):e167-80. PubMed ID: 24855048 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]